Dr. Yu Maw Htwe, MD

Dr. Htwe practices at Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey.

Dr. Htwe's NPI, 1780094136, was assigned on May 6, 2014. Dr. Htwe holds New Jersey license 25MA12257500.

Dr. Htwe's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD, at 200 S Orange Ave, Livingston, NJ 07039.

Dr. Htwe's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey. Dr. Htwe is also affiliated with Cooperman Barnabas Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Htwe to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Htwe practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Htwe's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Htwe's licenses on file in 3 states: New Jersey, Illinois and Pennsylvania.

CMS data shows 229 Medicare services from Dr. Htwe across 9 procedure codes in 2024, for 160 Medicare patients. Medicare paid $20,937 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Htwe in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Htwe's median patient age at 71, with 49% women.

In 2024, Dr. Htwe wrote 33 Medicare Part D claims for 21 patients. 70% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $6,843 in total drug cost. In 2020, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Htwe for performance year 2024, reported through an alternative payment model (APM). Dr. Htwe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Htwe as offering telehealth.

Dmand AI links 10 papers to Dr. Htwe, published from 2015 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Lung, Respiratory Distress Syndrome and Acute Lung Injury. Dr. Htwe's most frequent co-authors are Patrick George Belvitch, MD, Claudia I. Henschke, MD and David F. Yankelevitz, MD.

CMS Open Payments shows 59 general payments to Dr. Htwe from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $6,465.